Clinical Trial Update: Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the growth hormone–IGF-1 axis in children with chronic myelogenous leukemia in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelogenous Leukemia

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Chronic Myelogenous Leukemia, Short Stature | Phase 4 | Status: UNKNOWN